CTF1 and rheumatoid arthritis: In an earlier study, baicalin markedly reduced the serum levels of TG, total cholesterol (TC), and low-density lipoprotein (LDL)-cholesterol (LDL-C), but not HDL-C and apolipoproteins (APOs), in patients with coronary artery disease and rheumatoid arthritis, along with the inflammatory biomarkers cardiotrophin-1 (CT-1) and high-sensitivity C-reactive protein (hs-CRP) [25].